Cargando…
Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis
BACKGROUND: Inflammatory bowel disease (IBD) is a chronic, relapsing inflammation of the digestive tract. Although fecal and serum biomarkers have been extremely important and supportive for monitoring of IBD, their low sensitivity and high variability characteristics limit clinical efficacy. Thus,...
Autores principales: | Motooka, Kei, Morishita, Koichi, Ito, Nami, Shinzaki, Shinichiro, Tashiro, Taku, Nojima, Satoshi, Shimizu, Kayoko, Date, Mutsuhiro, Sakata, Natsumi, Yamada, Momoko, Takamatsu, Shinji, Kamada, Yoshihiro, Iijima, Hideki, Mizushima, Tsunekazu, Morii, Eiichi, Takehara, Tetsuo, Miyoshi, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807302/ https://www.ncbi.nlm.nih.gov/pubmed/33510557 http://dx.doi.org/10.3748/wjg.v27.i2.162 |
Ejemplares similares
-
Transcription factor SP1 regulates haptoglobin fucosylation via induction of GDP-fucose transporter 1 in the hepatoma cell line HepG2
por: Kondo, Jumpei, et al.
Publicado: (2022) -
Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
por: Kamada, Yoshihiro, et al.
Publicado: (2013) -
Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
por: Shirai, Kumiko, et al.
Publicado: (2022) -
Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression
por: Choi, Hyewon, et al.
Publicado: (2023) -
Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.
por: Thompson, S., et al.
Publicado: (1987)